Aprea Therapeutics Inc (APRE) Insider Trading
- $9,289,219.14
- $44,682,646.29
- March 13, 2024
- Scott M Rocklage
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 13, 2024 | Director | 6,860 | $7.29 | Buy | $50,009.40 | |
| March 13, 2024 | CFO | 1,010 | $7.29 | Buy | $7,362.90 | |
| March 13, 2024 | CEO | 2,000 | $7.29 | Buy | $14,580.00 | |
| June 6, 2023 | Director | 4,068 | $3.63 | Buy | $14,766.84 | |
| Feb. 28, 2022 | SVP | 36,000 | $1.73 | Sell | $62,280.00 | |
| Dec. 1, 2021 | SVP | 27,500 | $3.96 | Sell | $108,900.00 | |
| Oct. 1, 2021 | SVP | 50,000 | $4.89 | Sell | $244,500.00 | |
| Sept. 20, 2021 | SVP | 32,960 | $4.97 | Sell | $163,811.20 | |
| Sept. 16, 2021 | SVP | 15,968 | $4.68 | Sell | $74,730.24 | |
| Oct. 5, 2020 | Insider | 175,000 | $25.30 | Sell | $4,427,500.00 | |
| July 7, 2020 | Major Shareholder | 241,703 | $34.55 | Sell | $8,350,838.65 | |
| June 16, 2020 | Director | 120,164 | $33.30 | Sell | $4,001,461.20 | |
| June 16, 2020 | Major Shareholder | 140,000 | $33.30 | Sell | $4,662,000.00 | |
| June 11, 2020 | Director | 245,000 | $28.75 | Sell | $7,043,750.00 | |
| May 19, 2020 | Director | 255,000 | $35.15 | Sell | $8,963,250.00 | |
| April 13, 2020 | Major Shareholder | 210,548 | $31.25 | Sell | $6,579,625.00 | |
| Oct. 7, 2019 | Major Shareholder | 333,333 | $15.00 | Buy | $4,999,995.00 | |
| Oct. 7, 2019 | CFO | 2,500 | $15.00 | Buy | $37,500.00 | |
| Oct. 7, 2019 | Director | 266,667 | $15.00 | Buy | $4,000,005.00 | |
| Oct. 7, 2019 | CEO | 11,000 | $15.00 | Buy | $165,000.00 |
Insiders are both buying and selling Aprea Therapeutics Inc stock.
The insider traders at Aprea Therapeutics Inc are: Scott M Rocklage, Eyal C Attar, Gregory Alan Korbel, Ventures Iv L.P. 5Am, Kdev Investments Ab, Bernd R Seizinger, Vantage I L.P. Versant, Lars B Abrahmsen, Oren Gilad, Scott M Coiante, Christian S Schade, Johan Christenson, and John P Hamill
The most active insider trader at Aprea Therapeutics Inc is Scott M Rocklage with 3 trades.
Scott M Rocklage has sold the most Aprea Therapeutics Inc stock with a total value of $24,009,922.40.
Vantage I L.P. Versant has bought the most Aprea Therapeutics Inc stock with a total value of $9,999,990.00.
The most recent insider trade for Aprea Therapeutics Inc was on March 13, 2024.
The single biggest insider buy for Aprea Therapeutics Inc was from Vantage I L.P. Versant with a total value of $4,999,995.00 on Oct. 7, 2019.
The single biggest insider sell for Aprea Therapeutics Inc was from Scott M Rocklage with a total value of $8,963,250.00 on May 19, 2020.